Genetically humanized phenylketonuria mouse model as a testing tool for human genome editing in fertilized eggs

Documenti analoghi

• The clinical relevance of novel biomarkers as outcome parameter in adults with phenylketonuria
  di: A. M. J. van Wegberg, et al.
  Pubblicazione: (2024)
• A phenylalanine‐free recombinant nutritional protein for the dietary management of phenylketonuria
  di: Yvonne Mücke, et al.
  Pubblicazione: (2024)
• Protein requirements in adults with phenylketonuria and bioavailability of glycomacropeptide compared to an l‐amino acid‐based product
  di: Abrar Turki, et al.
  Pubblicazione: (2024)
• Reversible white matter changes following a 4‐week high phenylalanine exposure in adults with phenylketonuria
  di: Raphaela Muri, et al.
  Pubblicazione: (2024)
• Clinical pharmacology considerations for first‐in‐human clinical trials for enzyme replacement therapy
  di: Sydney Stern, et al.
  Pubblicazione: (2024)